Immunyx Pharma Selected to Join BLUE KNIGHT™

Immunyx Pharma, a developer of immune modulating therapies for neutrophil-based diseases, has been selected to join Blue Knight, a collaboration between Johnson & Johnson Innovation LLC and the Biomedical Advanced…

Continue Reading Immunyx Pharma Selected to Join BLUE KNIGHT™